| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 9.779 | 22.274 | 21.594 | 16.425 | 25.802 | 65.809 | 62.342 | 75.511 |
| Total Income - EUR | - | - | 9.779 | 22.303 | 21.697 | 16.425 | 25.812 | 65.809 | 63.071 | 76.134 |
| Total Expenses - EUR | - | - | 4.593 | 5.521 | 5.395 | 6.454 | 8.132 | 9.802 | 21.105 | 21.418 |
| Gross Profit/Loss - EUR | - | - | 5.186 | 16.782 | 16.303 | 9.971 | 17.680 | 56.006 | 41.966 | 54.716 |
| Net Profit/Loss - EUR | - | - | 4.892 | 16.113 | 15.652 | 9.510 | 16.998 | 54.476 | 41.430 | 52.477 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Alergolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.777 | 1.294 |
| Current Assets | - | - | 5.056 | 21.170 | 19.079 | 21.543 | 38.060 | 59.956 | 58.254 | 58.157 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 986 | 0 | 1.093 | 54 | 122 | 38.570 | 4.398 | 35.091 |
| Cash | - | - | 4.070 | 21.170 | 17.986 | 21.489 | 37.939 | 21.387 | 53.856 | 2.359 |
| Shareholders Funds | - | - | 4.936 | 20.959 | 18.459 | 21.362 | 37.887 | 54.524 | 58.952 | 52.525 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 120 | 211 | 620 | 181 | 174 | 5.432 | 1.078 | 6.925 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergolife Srl